Genetically Modified Organisms for Methyl Halide Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Industrial production of methyl halides currently relies on energy-intensive chemical methods, and biological methods using methyl halide transferases in organisms are not efficiently scalable for commercial production.
Innovation Solution
A process involving genetically modified organisms, such as algae, fungi, or bacteria expressing S-adenosylmethionine-dependent methyl halide transferase, combined with a halide and carbon source in a cultivation medium, to produce methyl halides, which can be converted into non-halogenated organic molecules using zeolite catalysts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical methods are used for industrial production of methyl halides, then production efficiency is improved, but energy consumption increases and harsh conditions (high temperature and pressure) are required
Solution Approach 1:
The invention changes the fundamental parameters of the production system by replacing chemical synthesis with biological synthesis. The methyl halide transferase enzyme catalyzes the reaction under mild physiological conditions (ambient temperature and pressure, neutral pH), completely eliminating the need for high temperature and pressure conditions while maintaining high production efficiency through enzymatic catalysis
Solution Approach 2:
The invention substitutes the mechanical/chemical synthesis system with a biological system. Instead of using chemical reagents and harsh physical conditions to drive the reaction, the patent employs a genetically modified organism expressing methyl halide transferase that naturally catalyzes the formation of methyl halides under benign conditions, thereby eliminating energy-intensive equipment and processes
2Productivity
If chemical methods are used for industrial production of methyl halides, then production efficiency is improved, but process complexity and safety risks increase
Solution Approach 1:
The invention replaces complex chemical synthesis equipment and multiple reaction steps with a single biological system. The genetically modified organism serves as a living factory that performs the entire synthesis process in one step under physiological conditions, eliminating the need for specialized high-pressure reactors, temperature control systems, and complex purification equipment
Solution Approach 2:
The genetically modified organism is self-sufficient in carrying out the synthesis. The organism's metabolic machinery automatically provides the necessary cofactors (ATP, S-adenosylmethionine) and maintains optimal conditions for enzyme activity, eliminating the need for external control systems and complex process monitoring
3Use of energy by moving object
If biological methods using methyl halide transferases are used, then energy consumption is reduced and sustainability is improved, but scalability for commercial production is insufficient
Solution Approach 1:
The invention uses a universal platform of genetically modified microorganisms (bacteria, yeast, or plant cells) that can be scaled from laboratory to industrial production. The same methyl halide transferase enzyme and genetic modification strategy can be applied across different organism types and production scales, enabling seamless transition from research to commercial manufacturing while maintaining low energy consumption
Solution Approach 2:
The invention transitions from small-scale batch culture to large-scale continuous bioreactor systems, adding the dimension of time and flow to the production process. This enables commercial-scale productivity by continuously cultivating and harvesting the genetically modified organisms in large bioreactors, thereby scaling up production without increasing energy consumption per unit of product
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the commercial-scale production of methyl halides and their conversion into valuable organic compounds like alkanes, olefins, and alcohols, offering a more sustainable and efficient alternative to traditional chemical methods.
Implementation Method 1
These organisms contain methyl halide transferases that combine a chlorine, bromine or iodine ion with a methyl group of the metabolite S-adenosylmethionine ('AdoMet' or 'SAM') to form the methyl halide and S-adenosyl homocysteine
Implementation Method 2
The methyl halide can be converted into a non-halogenated organic molecule or a mixture of non-halogenated organic molecules
Data Source
AI summary
Disclosed is a process in which a recombinant organism, such as a yeast, expressing a heterologous S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT) protein is combined with a halide and a carbon source in a cultivation medium under conditions in which methyl formate is produced. The cell may genetically modified to express methyl formate synthase, methanol dehydrogenase and/or hydrolytic dehalogenase at levels higher than a cell of the same species that is not genetically modified. The methyl formate may be collected and used in a variety of applications. The halide may be chlorine, bromine or iodine.